Medgend Icon

Ledgend of Medicine







discontinued


Factor

What is hemophilia?

Hemophilia is a rare bleeding disorder in which the blood does not clot properly. This can lead to problems with bleeding too much after an injury or surgery. You can also have sudden bleeding inside your body, such as in your joints, muscles, and organs.

Your blood contains many proteins called clotting factors that can help form clots to stop bleeding. People with hemophilia have low levels of one of these factors, usually either factor VIII (8) or factor IX (9). How severe the hemophilia is depends on the amount of factor in the blood. The lower the amount of the factor, the more likely it is that bleeding could happen and might lead to serious health problems.

What are the types of hemophilia?

There are several different types of hemophilia. The most common are:

  • Hemophilia A (classic hemophilia), which is caused by a lack or decrease of clotting factor VIII (8)
  • Hemophilia B (Christmas disease), which is caused by a lack or decrease of clotting factor IX (9)
What causes hemophilia?

Most types of hemophilia are inherited. They are caused by change in one of the genes (also called a mutation) that provides instructions for making the clotting factor proteins. The change may mean that the clotting proteins don't work properly or that they are missing altogether.

These genes are on the X chromosome. You may have one or two X chromosomes:

  • People who are born male have one X chromosome (from the mother) and one Y chromosome (from the father). They can get hemophilia if their one X chromosome has the gene change.
  • People who are born female have two X chromosomes, one from the father and one from the mother. They usually only get hemophilia if:
    • Both X chromosomes have the gene change OR
    • One X chromosome has the gene change and the other X chromosome is missing or inactive.

    People who are born female who have the gene change on one X chromosome are a "carrier" of hemophilia. Sometimes they may have some symptoms of hemophilia. They can pass the gene change on to their children.

Hemophilia that is not inherited is called acquired hemophilia. It is rare. It happens when your body makes specialized proteins called autoantibodies that attack and disable a clotting factor. This can happen because of pregnancy, immune system disorders, cancer, or allergic reactions to certain medicines. Sometimes the cause is unknown.

Who is at risk for hemophilia?

Hemophilia is much more common in people who were born male since they can get it with a change to the gene on one X chromosome. People who have a family history of hemophilia are also at higher risk.

What are the symptoms of hemophilia?

The signs and symptoms of hemophilia are:

  • Bleeding into the joints. This can cause swelling and pain or tightness in the joints. It often affects the knees, elbows, and ankles.
  • Bleeding into the skin (which is bruising).
  • Bleeding into the muscle and soft tissue, which can cause a build-up of blood in the area (called a hematoma).
  • Bleeding of the mouth and gums, including bleeding that is hard to stop after you lose a tooth.
  • Bleeding after circumcision.
  • Bleeding after having shots, such as vaccinations.
  • Bleeding in the head of an infant after a difficult delivery.
  • Blood in the urine or stool.
  • Frequent and hard-to-stop nosebleeds.

In some cases, severe hemophilia may cause bleeding in the brain. This may cause brain damage and can be life-threatening.

How is hemophilia diagnosed?

To find out if you have hemophilia, your health care provider will:

  • Ask about your medical history, including your symptoms and other health conditions you may have.
  • Ask about your family history, to find out if you have relatives who have or had hemophilia.
  • Do a physical exam to look for signs of hemophilia, such as bruising.
  • Do certain blood tests to show if your blood is clotting properly. If it does not, then you will have clotting factor tests to diagnose the cause of the bleeding disorder. These blood tests would show the type of hemophilia and the severity.

There is genetic testing for the factor VIII (8) and factor IX (9) genes. This testing may be used in people who have a family history of hemophilia to:

  • Identify people who are carriers before they make decisions about pregnancy
  • Test a fetus for hemophilia during pregnancy
  • Test a newborn for hemophilia
What are the treatments for hemophilia?

The best way to treat hemophilia is to replace the missing clotting factor so that your blood can clot properly. This is usually done by injecting replacement clotting factor into a vein. The replacement clotting factor may be made from donated human blood. Or it may be made in a lab; this kind is called a recombinant clotting factor.

Replacement clotting factor can help treat a bleeding episode. In more severe cases of hemophilia, you might get the factor on a regular basis to prevent bleeding. You can learn how to inject the factor so that you can do it yourself at home.

There are other medicines to treat hemophilia. They may work by releasing factor VIII (8) from where it is stored in the body tissues, replacing the function of factor VIII (8), or preventing clots from breaking down.

If bleeding has damaged your joints, physical therapy may help them function better.

Good quality medical care from healthcare professionals who know a lot about the disorder can help prevent some serious problems. Often the best choice for care is to visit a hemophilia treatment center (HTC).

Centers for Disease Control and Prevention

Factor FDA Approved Drugs

CRESTOR [Rosuvastatin Calcium2C22H27FN3O6SCa]
RX
-
10mg (oral tablet)
20mg (oral tablet)
40mg (oral tablet)
5mg (oral tablet)
IprAug 12, 2003
  • Treatment of pediatric patients 8 to 17 years of age with heterozygous familial hypercholesterolemia (hefh).
  • Use of rosuvastatin calcium for the primary prevention of cardiovascular disease in individuals without clinically evident coronary heart disease but with increased risk factors.
  • Use of rosuvastatin calcium to reduce elevated total-c, ldl-c, apob, nonhdl-c or tg levels; to increase hdl-c in adult patients with primary hyperlipidemia or mixed dyslipidemia; and to slow the progression of atherosclerosis..
efficacy
4.5  (2)
side effects
1.0  (1)
danger
1.0  (1)

UNK

CYCLOSET [Bromocriptine MesylateC32H40BrN5O5CH4O3S]
RX
-
eq 0.8mg base (oral tablet)
VeroscienceMay 5, 2009
  • Administration once daily within two hours after waking in the morning for improvement of glycemic control in a type 2 diabetes patient.
  • Improvement of glycemic control in individuals with type 2 diabetes.
  • Improvements of glycemic control in individuals with type 2 diabetes who have one or more specified cardiovascular risk factors.
  • Treatment of type 2 diabetes by administering bromocriptine mesylate and a first-phase insulin secretagogue wherein the combined therapeutic effect is greater than the additive effect of administering each agent alone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FASLODEX [FulvestrantC32H47F5O3S]
RX
-
50mg/ml (intramuscular injectable)
AstrazenecaApr 25, 2002
  • Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
  • Treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbococlib in women with disease progression after endocrine therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

IRESSA [GefitinibC22H24ClFN4O3]
RX
-
250mg (oral tablet)
Astrazeneca PharmsJul 13, 2015
  • First-line treatment of patients with metastatic non-small cell lung cancer (nsclc) whose tumors have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KISQALI [Ribociclib SuccinateC23H30N8OC4H6O4]
RX
-
eq 200mg base (oral tablet)
Novartis Pharms CorpMar 13, 2017
  • In combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her-2)-negative advanced or metastatic breast cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KISQALI FEMARA CO-PACK (COPACKAGED) [LetrozoleC17H11N5 : Ribociclib SuccinateC23H30N8OC4H6O4]
RX
-
2.5mg,n/a : n/a,eq 200mg base (oral tablet, tablet)
Novartis Pharms CorpMay 4, 2017
  • In combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her-2)-negative advanced or metastatic breast cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MOZOBIL [PlerixaforC28H54N8]
RX
-
24mg/1.2ml (20mg/ml) (subcutaneous solution)
GenzymeDec 15, 2008
  • Use in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hematopoietic stem cells to peripheral blood for collection & subsequent autologous transplantation in patients with non-hodgkin's lymphoma & multiple myeloma.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MULTAQ [Dronedarone HydrochlorideC31H44N2O5SClH]
RX
-
eq 400mg base (oral tablet)
Sanofi Aventis UsJul 1, 2009
  • Management of risk of dronedarone/beta-blocker interaction in patients in sinus rythm with a history of paroxysmal or persistent af.
  • Reduction in risk of hospitalization in patients with a history of paroxysmal or persistent af without severe heart failure and with one or more risk factors by administration twice a daily with morning and evening meals.
  • Reduction in risk of hospitalization in patients with coronary heart disease and a history of paroxysmal or persistent af and with one or more risk factors by administration twice a day with morning and evening meals.
  • Reduction in risk of hospitalization in patients with stable nyha class iii heart failure and a history of paroxysmal or persistent af and with one or more risk factors by administration twice a day with morning and evening meals.
  • Reduction of the risk of cardiovascular hospitalization.
  • Reduction of the risk of hospitalization for atrial fibrillation.
  • Treatment of patients with a history of paroxysmal or persistent af without severe heart failure and with one or more risk factors by administration twice a day with morning and evening meals.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

POMALYST [PomalidomideC13H11N3O4]
RX
-
1mg (oral capsule)
2mg (oral capsule)
3mg (oral capsule)
4mg (oral capsule)
CelgeneFeb 8, 2013
  • Use of pomalidomide for the treatment of multiple myeloma.
  • Use of pomalidomide to inhibit the secretion of pro-inflammation cytokines, including tumor necrosis factor alpha.
  • Use of pomalidomide while preventing the exposure of a fetus or other contraindicated individual to pomalidomide.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

REVLIMID [LenalidomideC13H13N3O3]
RX
-
10mg (oral capsule)
15mg (oral capsule)
2.5mg (oral capsule)
20mg (oral capsule)
25mg (oral capsule)
CelgeneDec 27, 2005
  • Treatment of male patient having a disease or condition responsive to a teratogenic drug.
  • Use of revlimid (lenalidomide) for the treatment of mantle cell lymphoma (mcl).
  • Use of revlimid (lenalidomide) for the treatment of multiple myeloma and transfusion-dependent anemia in myelodysplastic syndromes (mds).
  • Use of revlimid (lenalidomide) for the treatment of multiple myeloma.
  • Use of revlimid (lenalidomide) for the treatment of transfusion-dependent anemia in myelodysplastic syndromes (mds).
  • Use of revlimid (lenalidomide) to inhibit the secretion of pro-inflammatory cytokines, including tumor necrosis factor alpha.
  • Use of revlimid (lenalidomide) while preventing the exposure of a fetus or other contraindicated individual to revlimid (lenalidomide).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TAGRISSO [Osimertinib MesylateC28H33N7O2CH4O3S]
RX
-
eq 40mg base (oral tablet)
eq 80mg base (oral tablet)
Astrazeneca PharmsNov 13, 2015
  • Treatment of patients with metastatic epidermal growth factore receptor (egfr) t790m mutation-positive non-small cell lung cancer (nsclc), who have progressed on or after egfr tki therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Factor

ABIES (Tsuga canadensis)TSCA
   The bark and prepared resinous exudate of Tsuga canadensis, Carriére (Abies canadensis, Michaux; Pinus canadensis, Linné). (Nat. Ord.... / ...oea. Contraindicated in inflammations. Therapy.—External. A strong decoction of the bark is a satisfactory astringent for the checking of leucorrhoea and a good local application of this type for aph... / ...be used where there is excessive secretion of mucus and the cough is largely precipitated by a feeble and relaxed state of the uvula and fauces. 1

APOCYNUM CANNABINUM
   The root of Apocynum cannabinum, Linné (Nat. Ord. Apocynaceae) gathered in autumn after the leaves and fruit have matured. Grows throughout the... / ...r, or kidneys. Yet in these conditions, when debility and subcutaneous, watery exudation are strong factors, it alone is a powerful remedy to relieve urgent symptoms and to put into action that portio... / ...enormous dropsical swellings with it, giving quick relief from dyspnea and1

ASAFOETIDA (Ferula fetida)
   A gum-resin derived from the rhizome and rootlets of Ferula Asafetida, Linné; Ferula foetida, Regel, and other species of Ferula (Nat. Ord.... / ...ic of children and flatus due to intestinal indigestion of old persons, asafetida is extremely satisfactory. Tympanites occurring during fevers is often relieved by it, for its carminative influence i... / ...or tardy or imperfect menstruation. Asafetida is contraindicated by inflammation. It may be given in emulsion, tincture, or pill or capsule. 1

CACTUS (Selenicereus spp.)
   The fresh, green stems and the flowers of Selenicereus grandiflorus (L.) Britt. & Rose (and other Selenicereus species—MM) (Cereus grandiflorus,... / ...us, Large-flowering Cactus, Sweet-scented Cactus. Principal Constituents.—Cactus has not been satisfactorily analyzed. Preparation.—Specific Medicine Cactus. Dose, 1 to 10 drops. Specific Indication... / ...organ were held with a strong band, it is often the most prompt of all cardiac remedies. It is a good remedy in the heart troubles produced by to1

CAFFEA
   The seeds of Caffea arabica, Linné (Nat. Ord. Rubiaceae). Native of Arabia-Felix and Ethiopia; and extensively cultivated in Asia and America... / ...s a beverage. In fact, coffee should never be wholly withheld in acute disorders when it has been a factor in the patient's daily dietary. For its stimulating effect in fatigue and nervous exhaustion ... / ...be given freely, both by mouth and per rectum.1

CHIONANTHUS
   The bark of the root of Chionanthus virginicus, Linné. (Nat. Ord. Oleaceae.) United States from Pennsylvania southward. Dose, 5 to 30... / ...rted by many whose large experience entitles them to credence that chionanthus is a potent and satisfactory medicinal aid in glycosuria, when the glycogenic function of the liver is at fault. While it... / ...never reach the true diabetic state. There is good reason to believe that the prolonged use of chionanthus will be of much benefit in such cases.1

CINNAMOMUM
   I. Cinnamomum Saigonicum. Dried bark of an undetermined species of Cinnamomum. Chiefly from China. II. Cinnamomum Zeylanicum. Dried bark of... / ...motor control of the pulmonic vessels. But cinnamon has given results which have been entirely satisfactory. Hemorrhages from the stomach, bowels, and renal organs are often promptly checked by the ti...1

CONIUM
   The full grown fruit, gathered green, of Conium maculatum, Linné (Nat. Ord. Umbelliferae). Europe and Asia; naturalized in the United... / ...scles is present, in laryngismus stridulus, also in whoopingcough, but we have safer and more satisfactory remedies for these affections. Some cases of epilepsy due to masturbation have been relieved... / ...be applied and be given to relieve pain even when a cure is not possible. It relieves the pain of swollen mammae during the menstrual periods a1

ECHINACEA
   The dried root of Brauneria angustifolia, Linné (Echinacea angustifolia [DeCandolle], Heller). (Nat. Ord. Compositae.) In rich prairie soils of... / ...yosalpinx, and thecal abscesses. Action.—The physiological action of echinacea has never been satisfactorily determined. It has been held to increase phagocytosis and to improve both leukopenia and h... / ...cent solution to full strength echinacea or echafolta may be freely used, syringing the channels with it. This gives great relief from pain 1

EPILOBIUMEPPU2
   The leaves and tops of Epilobium angustifolium, Linné, and Epilobium palustre, Linné (Nat. Ord. Onagraceae). North America. Dose, 10 to 60... / ... Wickop, Swamp Willow Herb, Marsh Epilobium. Principal Constituents.—The plants have not been satisfactorily examined. Preparations.—1. Infusum Epilobii, Infusion of Epilobium (1 ounce to water, 16 ... / ...preparation. It may be prepared in the usual way, and aromatized with essence of peppermint and preserved with a small quantity of glycerin.1

ERYNGIUM
   The rhizome of Eryngium yuccifolium, Michaux (Nat. Ord. Umbelliferae). A swamp and wet prairie plant found from Virginia to Texas. Dose, 10 to 40... / ...ccompanied by the involuntary passing of urine. We know of no remedy that acts so promptly and satisfactorily in such conditions. In the male it relieves uneasy sensations, with burning and itching th... / ...gastric irritation and mucous diarrhoea. In these cases the tongue is red and tender, nausea is marked, and there is a strong for food.1

EUCALYPTUSEUAN12
   The leaves of Eucalyptus Globulus, Labillardiere. Collected from the older parts of the tree. (Nat. Ord. Myrtaceae.) A native tree of Australia; cultivated... / ...ary run of malarial fevers. Used according to indications as given above, eucalyptus is a very satisfactory and pleasant medicine. It is best given in syrup or glycerin.1

EUPATORIUM PURPUREUM
   The root of Eupatorium purpureum, Linné (Nat. Ord. Compositae). Low meadows and woods of the United States. Dose, 5 to 60 grains. Common Names:... / ...to relieve chronic irritation of the urinary passages. For this purpose it is one of the most satisfactory of medicines. It is adapted to cases in which there is constant urging to pass urine, accomp... / ...acts well with the special sedatives, and if fever is present or the skin is hot, dry, and constricted it may be given with aconite or gelsemium.1

HYDRASTISHYDRA2
   The dried rhizome and roots of Hydrastis canadensis, Linné (Nat. Ord. Ranunculaceae) United States and Canada in rich, shady woods. (Chiefly... / ...g cough and nausea, hydrastis given internally and as an ingredient of a local wash gives very satisfactory results. In all catarrhal affections of the upper respiratory tract, hydrastis should be adm... / ...The preparation preferred is the colorless, though other hydrastis preparations, particularly berberine and hydrastin salts are useful, b1

IRISIRIS
   The rhizome and roots of Iris versicolor, Linné (Nat. Ord. Iridaceae). Common in wet places in the United States. Dose, 5 to 20 grains. Common... / ...l completely. The exact type most benefited has never been clearly defined. In order to obtain satisfactory results at all, the use of the drug must be continued over a period of several months. In ex...1


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Materia Medica on Factor

IODOSYL
   An organic chemical compound containing a little more than 655 of Iodine; empirical formula, C7H4O3I2. An amorphous powder, non toxic and free from irritant action, yet having antiseptic properties that make it invaluable in surgery. It may be used wherever iodo form is now employed with effects at least equally satisfactory. The results obtained with it in treating ulcerations of the cornea are par ticularly gratifying. It may be given internally as a gastric anti septic, in doses of 0.03 to 0.2


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Therapeutics Memoranda on Factor

DIPHTHERIA AND MEMBRANOUS CROUP
   Isolate the patient and watch carefully all children who... / ...may have been exposed. In every case use Diphtheria Antitoxin if at hand and use it promptly. As local application, peroxide of hydrogen is most satisfactory. Loefl1er’s solution (menthol, 100 grs. dissolved in 6 fluidrachms toluol, with addition of 40 minims solution ferric chloride and 10 fluidr...2


References

1) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.
2) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.